Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Genetic Technologies Ltd (GENE : NSDQ)
 
 • Company Description   
Genetic Technologies was the first company in the world to recognize important new applications for `non-coding` DNA (DeoxyriboNucleic Acid). The Company has since been granted patents securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species.

Number of Employees: 18

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.30 Daily Weekly Monthly
20 Day Moving Average: 62,197 shares
Shares Outstanding: 15.39 (millions)
Market Capitalization: $20.08 (millions)
Beta: 2.00
52 Week High: $5.18
52 Week Low: $0.95
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -26.27% -16.97%
12 Week -30.58% -23.69%
Year To Date -30.58% -14.86%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
60-66 Hanover Street
-
Fitzroy,C3 3065
AUS
ph: 011-61-3-8412-7000
fax: 011-61-3-8412-7040
ir@gtgcorporate.com http://www.gtglabs.com
 
 • General Corporate Information   
Officers
Simon Morriss - Chief Executive Officer
Peter Rubinstein - Chairman and Director
Stanley Sack - Chief Operating Officer
Mike Tonroe - Chief Financial Officer and Company Secretary
Lindsay Wakefield - Director

Peer Information
Genetic Technologies Ltd (CORR.)
Genetic Technologies Ltd (RSPI)
Genetic Technologies Ltd (CGXP)
Genetic Technologies Ltd (BGEN)
Genetic Technologies Ltd (GTBP)
Genetic Technologies Ltd (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 37185R307
SIC: 2836
Fiscal Year
Fiscal Year End: June
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 15.39
Most Recent Split Date: 8.00 (0.25:1)
Beta: 2.00
Market Capitalization: $20.08 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.42
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - -
12/31/21 - 6.08
09/30/21 - -
Quick Ratio
03/31/22 - -
12/31/21 - 5.96
09/30/21 - -
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - 0.92
09/30/21 - -
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.00
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - 0.17
09/30/21 - -
 

Powered by Zacks Investment Research ©